Payne Joseph E 4
4 · Arcturus Therapeutics Ltd. · Filed Feb 11, 2019
Insider Transaction Report
Form 4
Payne Joseph E
President and CEO10% Owner
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-02-07$4.99/sh+60,000$299,400→ 60,000 totalExercise: $4.99Exp: 2029-02-06→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The grant of options to the Reporting Person is subject to shareholder approval under the Companies Law 5759-1999 of the State of Israel; options vest over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter.